Stephen M. Sagar, MD | Authors


Carcinomatous Meningitis: It Does Not Have to Be a Death Sentence

February 01, 2002

Carcinomatous meningitis, specifically leptomeningeal metastases from solid tumors, has a dismal prognosis, with an overall median survival of 2 to 4 months. Lymphomatous meningitis has a better outlook, with a median survival of more than 6 months, but diagnosis may be delayed and treatment is not curative.